• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Stoneleigh Partners Acquisition

Stoneleigh Partners Acquisition

Telkom SA SOC Ltd ADR TLKGY

Last Price$23.41Day Change (%)2.88%
Open Price$23.47Day Change ($)0.66
Day Range23.41–23.5452-Week Range10.37–25.26

As of Fri 12/19/2014 12:59 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Microsemi's Ultra-secure SmartFusion2 SoC FPGAs and IGLOO2 FPGAs Recognized on EDN's List of Hot 100 Products of 2014

    Microsemi's Ultra-secure SmartFusion2 SoC FPGAs and IGLOO2 FPGAs Recognized on EDN's List of Hot 100 Products of 2014

  2. IDT Surpasses Milestone of 3 Million Low-Power PCIe Gen3 Buffers Shipped

    IDT Surpasses Milestone of 3 Million Low-Power PCIe Gen3 Buffers Shipped

  3. Altera Demonstrates Industry's Highest Performance DDR4 Memory Data Rates in an FPGA

    Altera Demonstrates Industry's Highest Performance DDR4 Memory Data Rates in an FPGA

  4. Toshiba Supplies Traction Energy Storage System for Tobu Railway

    Toshiba Supplies Traction Energy Storage System for Tobu Railway

  5. Faraday Technology Corporation Selects Synopsys Virtualizer to Accelerate Software Development for SoC Designs

    Faraday Technology Corporation Selects Synopsys Virtualizer to Accelerate Software Development for SoC Designs

  6. ams Expands Family of Power Management ICs for Nvidia Tegra and Other Multi-Core ARM Processors

    ams Expands Family of Power Management ICs for Nvidia Tegra and Other Multi-Core ARM Processors

  7. Cadence Perspec System Verifier Delivers Up to 10X Productivity Improvement in System-on-Chip Verification

    Cadence Perspec System Verifier Delivers Up to 10X Productivity Improvement in System-on-Chip Verification

  8. Increasing Investments in R&D Will Boost Use of Lasers for Data Storage from 2015-2019: TechNavio

    Increasing Investments in R&D Will Boost Use of Lasers for Data Storage from 2015-2019: TechNavio

  9. Increased Spending on R&D Will Contribute to the Growth of the Global Mobile DRAM Market: TechNavio

    Increased Spending on R&D Will Contribute to the Growth of the Global Mobile DRAM Market: TechNavio

  10. Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

    Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.